Sildenafil for Erectile Dysfunction Treatment
Sildenafil (Viagra) should be offered as first-line therapy for erectile dysfunction unless contraindicated, with an initial dose of 50mg taken approximately 1 hour before sexual activity. 1, 2
Cardiovascular Risk Assessment
Before initiating sildenafil therapy, it's essential to assess cardiovascular risk and categorize patients:
High-risk patients (unstable/refractory angina, uncontrolled hypertension, CHF NYHA class II+, recent MI/CVA within 2 weeks, high-risk arrhythmias, hypertrophic cardiomyopathies, moderate-severe valvular disease) should not receive treatment until cardiac condition is stabilized 1, 2
Low-risk patients (asymptomatic coronary artery disease with <3 risk factors, controlled hypertension, mild stable angina, successful coronary revascularization, uncomplicated past MI, mild valvular disease, CHF NYHA class I) may receive sildenafil 1
Intermediate-risk patients should undergo cardiology evaluation before treatment 1, 2
Absolute Contraindications
- Concurrent use of nitrates in any form (tablets, patches, sprays, ointments) 1, 3
- Use of "poppers" (amyl nitrate/nitrite) 3
Dosing and Administration
- Initial dose: 50mg taken as needed approximately 1 hour before sexual activity 4
- Dose adjustment: Can be increased to 100mg or decreased to 25mg based on efficacy and tolerability 4
- Maximum frequency: No more than once daily 3
- Special populations: Lower starting dose (25mg) recommended for:
- Elderly patients
- Hepatic or renal impairment
- Patients taking CYP3A4 inhibitors (ritonavir, saquinavir, ketoconazole, erythromycin, cimetidine) 4
Proper Medication Use Instructions
To maximize effectiveness, instruct patients to:
- Take on an empty stomach (especially sildenafil) 2
- Allow sufficient time for onset of action (30-60 minutes) 2
- Ensure adequate sexual stimulation 2
- Try medication on multiple occasions before concluding it doesn't work 2
Common Side Effects
- Headache (11%)
- Flushing
- Dyspepsia (9%)
- Nasal congestion
- Visual disturbances (color-tinge to vision, increased light sensitivity)
- Dizziness 3, 4
Monitoring and Follow-up
Regular follow-up is recommended to:
Special Considerations
Diabetes: Sildenafil has demonstrated efficacy and safety in diabetic patients with erectile dysfunction, with 56% reporting improved erections compared to 10% with placebo 5
Visual/Hearing changes: Patients should seek immediate medical attention for sudden vision loss (possible NAION) or hearing decrease/loss 3
Drug interactions: Exercise caution with alpha-blockers due to potential hypotension 2
Treatment failure: If sildenafil fails after adequate trials, consider:
- Different PDE5 inhibitor (tadalafil, vardenafil)
- Second-line therapies (alprostadil intra-urethral suppositories, intracavernous injections)
- Vacuum constriction devices
- Penile prostheses 2
Sildenafil has proven to be an effective oral treatment for erectile dysfunction across various etiologies, with significant improvements in erection quality and sexual satisfaction compared to placebo 4, 6.